István Gyertyán Selected Research

István Gyertyán Research Topics

Disease

11	Schizophrenia (Dementia Praecox) 01/2018 - 10/2007
6	Cognitive Dysfunction 06/2023 - 05/2005
3	Catalepsy 11/2011 - 10/2007
3	Cocaine-Related Disorders (Cocaine Addiction) 03/2007 - 01/2003
2	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 01/2021
2	Obesity 01/2018 - 01/2017
2	Body Weight (Weight, Body) 01/2018 - 01/2017
2	Mania (Manias) 12/2017 - 10/2017
2	Bipolar Disorder (Manic Depressive Psychosis) 10/2017 - 09/2015
2	Anhedonia 10/2017 - 09/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 07/2009
2	Mental Disorders (Mental Disorder) 03/2014 - 05/2005
2	Shock 08/2012 - 01/2012
2	Psychotic Disorders (Schizoaffective Disorder) 04/2011 - 05/2005
2	Substance-Related Disorders (Drug Abuse) 05/2005 - 10/2003
1	Hemorrhage 09/2022
1	Amyloid Plaque 01/2021
1	Inflammation (Inflammations) 01/2018
1	Major Depressive Disorder (Major Depressive Disorders) 10/2017
1	Hypothermia 12/2015
1	Sleep Deprivation 11/2014
1	Hyperalgesia 12/2012
1	Pain (Aches) 12/2012
1	Central Nervous System Diseases (CNS Diseases) 04/2011
1	Neurobehavioral Manifestations 11/2008
1	Amnesia (Dissociative Amnesia) 05/2005

Drug/Important Bio-Agent (IBA)

8	cariprazineIBA 01/2018 - 11/2011
8	Dopamine (Intropin)FDA LinkGeneric 01/2018 - 10/2003
7	Dopamine D3 ReceptorsIBA 12/2017 - 01/2003
4	Phencyclidine (Angel Dust)IBA 01/2018 - 08/2012
4	Antipsychotic Agents (Antipsychotics)IBA 10/2017 - 11/2008
3	Serotonin (5 Hydroxytryptamine)IBA 01/2018 - 04/2011
3	Antidepressive Agents (Antidepressants)IBA 09/2014 - 08/2012
3	LigandsIBA 08/2012 - 01/2003
2	Selegiline (E250)FDA LinkGeneric 06/2023 - 01/2018
2	Streptozocin (Streptozotocin)FDA Link 11/2022 - 01/2021
2	gamma-Aminobutyric Acid (GABA)IBA 01/2018 - 12/2012
2	Glutamic Acid (Glutamate)FDA Link 01/2018 - 01/2018
2	Haloperidol (Haldol)FDA LinkGeneric 11/2008 - 10/2007
2	Scopolamine (Hyoscine)FDA Link 11/2008 - 05/2005
2	SB 277011IBA 10/2007 - 05/2005
1	Dinoprostone (PGE2)FDA Link 09/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Monoamine Oxidase (MAO)IBA 01/2018
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018
1	Glutamate Receptors (Glutamate Receptor)IBA 12/2017
1	Imipramine (Janimine)FDA LinkGeneric 10/2017
1	Aripiprazole (Abilify)FDA Link 10/2017
1	Appetite Depressants (Anorectics)IBA 01/2017
1	Nootropic Agents (Nootropics)IBA 01/2017
1	SZR 72IBA 12/2015
1	Escitalopram FDA Link 11/2014
1	3'- (5- (1- hydroxy- 1- methylethyl)benzoimidazol- 1- yl)biphenyl- 2- carbonitrileIBA 12/2012
1	L 838,417IBA 12/2012
1	Formaldehyde (Formol)FDA Link 12/2012
1	N- (2,6- dimethoxybenzyl)- N'- (4- (4- fluorophenyl)thiazol- 2- yl)guanidineIBA 08/2012
1	diphenyl (biphenyl)IBA 08/2012
1	SB-699551-AIBA 08/2012
1	Anti-Anxiety Agents (Anxiolytics)IBA 08/2012
1	Guanidine (Guanidine Nitrate)FDA Link 08/2012
1	Amphetamine (Amfetamine)FDA LinkGeneric 08/2012
1	serotonin 5 receptorIBA 08/2012
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2012
1	serotonin 6 receptorIBA 04/2011
1	SB 258585IBA 04/2011
1	LipidsIBA 07/2009
1	Diazepam (Valium)FDA LinkGeneric 11/2008
1	S 33084IBA 10/2007
1	benzamideIBA 03/2007
1	N- (4- (4- (3- aminocarbonyl- phenyl)- piperazin- 1- yl)- butyl)- 4- bromo- benzamideIBA 03/2007
1	(5,6-dimethoxyindan-2-yl)dipropylamineIBA 05/2005
1	BP 897IBA 05/2005
1	1- (2- methoxy- phenyl)- 4- (4- (4- (6- imidazol(2,1- b) thiazolyl)- phenoxy)- butyl- 4- (14)C)- piperazine dimethaneIBA 05/2005
1	Cocaine (Cocaine HCl)IBA 10/2003

Therapy/Procedure

1	Ligation 12/2012
1	Self Administration (Administration, Self) 10/2003